Welcome to datamethods
|
|
1
|
11982
|
July 24, 2018
|
Use of percentage change in clinical trials
|
|
17
|
1406
|
July 22, 2024
|
Plain language in published papers and specialist correspondence
|
|
0
|
104
|
July 21, 2024
|
How do we mistake biological plausibility for clinical relevance?
|
|
16
|
756
|
July 18, 2024
|
Good reading on when "doubly robust" is worth the effort?
|
|
2
|
242
|
July 15, 2024
|
What is the vintage of this result?
|
|
2
|
301
|
July 15, 2024
|
Bayesian subgroup analysis - interaction tests & general strategy
|
|
10
|
4930
|
July 11, 2024
|
Time for a change in language: statistical divergence and the 95% non-divergent interval (95%nDI)
|
|
28
|
1637
|
June 30, 2024
|
Waist-to-height ratio or waist circumference, adjusted for height, as outcomes
|
|
3
|
270
|
June 6, 2024
|
Compressing time-units in Markov Longitudinal Ordinal Models
|
|
6
|
286
|
June 3, 2024
|
Box-Cox transformation
|
|
3
|
275
|
May 15, 2024
|
Including Special Content
|
|
0
|
228
|
May 3, 2024
|
Censored Ordinal Outcome in blrm
|
|
2
|
214
|
May 3, 2024
|
External validation of a time-to-event prognostic model
|
|
2
|
424
|
May 2, 2024
|
Basic general doubt about Mendelian randomization
|
|
6
|
649
|
May 2, 2024
|
Can we think of competing-event as another form of non-event in terms of utility?
|
|
0
|
319
|
April 21, 2024
|
When should Standardized Mean Differences (SMD) be used? If there is a significant difference, is Cox regression or Propensity Score Matching more appropriate?
|
|
1
|
247
|
April 17, 2024
|
Overall survival vs disease-free survival and other surrogate endpoints
|
|
5
|
6934
|
April 11, 2024
|
Overlap weights for small sample RCTs
|
|
18
|
728
|
April 11, 2024
|
Hybrid AI & Delphi Based Derivation of RCT and Bedside Measurements
|
|
10
|
707
|
April 10, 2024
|
When is it clinically reasonable to assume transportability of RCT effects?
|
|
7
|
492
|
April 7, 2024
|
Executable Specification of Dose Escalation Oncology Protocol now on Arxiv
|
|
2
|
360
|
March 16, 2024
|
Communicating statistical concerns to the FDA
|
|
3
|
499
|
March 11, 2024
|
Tresholds in bayesian designs
|
|
0
|
249
|
March 6, 2024
|
Some thoughts on uniform prior probabilities when estimating P values and confidence intervals
|
|
15
|
931
|
February 11, 2024
|
Time to pre-randomization monthly seizure count
|
|
1
|
317
|
February 8, 2024
|
Is there a way to display the reference category(ies) in a regression output in rms?
|
|
6
|
635
|
February 2, 2024
|
Recommendations for the development of prediction models for small sample studies (rare disease/low outcome)
|
|
1
|
411
|
February 1, 2024
|
I'd be interested in any views on this attempt to predict COVID-19 hospitalizations using SARS-CoV-2 concentrations in wastewater (sewage)
|
|
8
|
1007
|
January 13, 2024
|
DOOR vs Win Ratio vs Ordinal Logistic Regression
|
|
3
|
458
|
January 24, 2024
|